Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CV Sciences (CVSI) Equity Average (2016 - 2025)

CV Sciences' Equity Average history spans 14 years, with the latest figure at $1.7 million for Q3 2025.

  • For Q3 2025, Equity Average fell 28.88% year-over-year to $1.7 million; the TTM value through Sep 2025 reached $1.7 million, down 28.88%, while the annual FY2024 figure was $2.3 million, 120.98% up from the prior year.
  • Equity Average for Q3 2025 was $1.7 million at CV Sciences, down from $1.8 million in the prior quarter.
  • Across five years, Equity Average topped out at $11.6 million in Q1 2021 and bottomed at $294000.0 in Q4 2022.
  • The 5-year median for Equity Average is $2.6 million (2024), against an average of $4.1 million.
  • The largest annual shift saw Equity Average tumbled 96.0% in 2022 before it surged 985.37% in 2023.
  • A 5-year view of Equity Average shows it stood at $7.3 million in 2021, then crashed by 96.0% to $294000.0 in 2022, then soared by 985.37% to $3.2 million in 2023, then crashed by 37.54% to $2.0 million in 2024, then fell by 16.16% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Equity Average are $1.7 million (Q3 2025), $1.8 million (Q2 2025), and $1.8 million (Q1 2025).